Certainly! When supplementing and improving product information for a biological product like HIV-1 Subtype D Positive Plasma, it is important to provide comprehensive details that address the needs of researchers and users while ensuring safety and compliance. Below is a structured approach to enhancing the product information:

---

Product Name: HIV-1 Subtype D Positive Plasma

Storage:
- Store at -80°C to maintain stability and activity. Avoid repeated freeze-thaw cycles to preserve plasma integrity.
- Once thawed, keep plasma at 2-8°C and use within 24 hours for optimal results.
- Ensure that storage facilities comply with biosafety regulations to prevent contamination or degradation.

Product Description:
- HIV-1 Subtype D Positive Plasma is collected from individuals infected with the HIV-1 subtype D virus.
- The plasma is screened and tested to confirm the presence of HIV-1 subtype D using advanced molecular techniques.
- It is characterized by a high viral load, making it suitable for various research applications.

Key Features:
- High Specificity: Contains HIV-1 subtype D, crucial for subtype-specific research and diagnostic development.
- Quality Assurance: Rigorous testing ensures purity and authenticity, with detailed batch records available.
- Reliability: Consistent viral load across batches for reproducible research outcomes.
- Compliance: Meets regulatory standards for research and development purposes.

What's Included:
- HIV-1 Subtype D Positive Plasma in designated volume aliquots (e.g., 0.5 mL or 1 mL vials).
- Certificate of Analysis (CoA) detailing viral load, subtype confirmation, and other relevant data.
- Safety data sheet (SDS) outlining handling precautions and emergency measures.

Applications:
- Research: Ideal for virology studies focusing on HIV-1 subtype D pathogenesis, transmission, and resistance mechanisms.
- Diagnostics Development: Supports the development and validation of diagnostic tests specifically targeting HIV-1 subtype D.
- Vaccine Research: Provides a basis for developing vaccines aimed at subtype-specific immune responses.
- Therapeutics Testing: Useful for evaluating the efficacy of antiviral drugs against HIV-1 subtype D.

---

Note: When handling HIV-1 Positive Plasma, it is crucial to follow strict biosafety protocols to prevent exposure and ensure laboratory safety. Always use appropriate personal protective equipment (PPE) and work within a certified biosafety cabinet.

This enhanced product information should serve as a comprehensive resource for users, aiding in informed decision-making and ensuring safe and effective use of the biological product.